Hepion Pharmaceuticals (HEPA) Short Interest Ratio & Short Volume $0.49 -0.04 (-7.37%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Hepion Pharmaceuticals Short Interest DataHepion Pharmaceuticals (HEPA) has a short interest of 47,200 shares, representing 0.68% of the float (the number of shares available for trading by the public). This marks a -26.59% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.1, indicating that it would take 1.1 days of the average trading volume of 80,071 shares to cover all short positions.Current Short Interest47,200 sharesPrevious Short Interest64,300 sharesChange Vs. Previous Month-26.59%Dollar Volume Sold Short$31,529.60Short Interest Ratio1.1 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares6,958,000 sharesFloat Size6,950,000 sharesShort Percent of Float0.68%Today's Trading Volume48,091 sharesAverage Trading Volume80,071 sharesToday's Volume Vs. Average60% Short Selling Hepion Pharmaceuticals? Sign up to receive the latest short interest report for Hepion Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartHEPA Short Interest Over TimeHEPA Days to Cover Over TimeHEPA Percentage of Float Shorted Over Time Ad Crypto 101 MediaTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Hepion Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/202447,200 shares $31,529.60 -26.6%0.7%1.1 $0.67 11/15/202464,300 shares $43,724.00 -2.1%0.9%1.6 $0.68 10/31/202465,700 shares $42,639.30 +247.6%1.1%1.5 $0.65 10/15/202418,900 shares $10,757.88 -24.7%0.3%0.4 $0.57 9/30/202425,100 shares $16,817.00 -59.9%0.4%0.2 $0.67 9/15/202462,600 shares $46,324.00 -17.3%1.1%0.4 $0.74 Get the Latest News and Ratings for HEPA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hepion Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/31/202475,700 shares $63,436.60 -6.8%1.3%0.5 $0.84 8/15/202481,200 shares $54,785.64 -29.5%1.4%0.5 $0.67 7/31/2024115,200 shares $90,178.56 +852.1%2.0%0.7 $0.78 7/15/202412,100 shares $12,826.00 -50.4%0.2%0.1 $1.06 6/30/202424,400 shares $24,890.44 +58.4%0.5%0.7 $1.02 6/15/202415,400 shares $17,078.60 -40.1%0.3%0.4 $1.11 5/31/202425,700 shares $32,382.00 -21.7%0.5%0.6 $1.26 5/15/202432,800 shares $38,048.00 -48.7%0.6%0.7 $1.16 4/30/202463,900 shares $87,223.50 -0.2%1.2%0.9 $1.37 4/15/202464,000 shares $139,520.00 +1.9%1.2%0.8 $2.18 3/31/202462,800 shares $156,372.00 +11.0%1.5%0.8 $2.49 3/15/202456,600 shares $127,916.00 -19.6%1.3%0.7 $2.26 2/29/202470,400 shares $209,088.00 -11.0%1.6%0.8 $2.97 2/15/202479,100 shares $211,988.00 +18.2%1.9%0.9 $2.68 1/31/202466,900 shares $127,110.00 -17.7%1.6%0.9 $1.90 1/15/202481,300 shares $223,575.00 -18.0%1.9%1.2 $2.75 12/31/202399,200 shares $321,408.00 -18.5%2.3%1.5 $3.24 12/15/2023121,700 shares $484,366.00 -61.6%2.8%1.9 $3.98 11/30/2023317,200 shares $1.02 million -4.4%7.4%5.7 $3.22 11/15/2023331,700 shares $959,011.04 +15.0%7.8%6.8 $2.89 10/31/2023288,500 shares $1.35 million -22.8%6.9%8.8 $4.67 10/15/2023373,700 shares $1.72 million -11.4%9.9%12.3 $4.61 9/30/2023421,900 shares $2.11 million +10.5%11.2%15.7 $4.99 9/15/2023381,700 shares $2.00 million +24.9%10.1%13.3 $5.25 8/31/2023305,700 shares $2.28 million +3.1%8.0%8.9 $7.45 8/15/2023296,600 shares $2.07 million -8.9%7.7%0.8 $6.99 7/31/2023325,700 shares $2.59 million +2.4%8.6%0.9 $7.95 7/15/2023318,000 shares $3.18 million -1.8%8.4%0.9 $9.99 6/30/2023323,800 shares $3.40 million -11.1%8.5%0.9 $10.50 6/15/2023364,100 shares $4.21 million +52.9%9.6%1 $11.57 5/31/2023238,200 shares $2.29 million +237.4%6.3%0.7 $9.60 5/15/202370,600 shares $473,020.00 +105.8%1.9%0.2 $6.70 4/30/2023685,900 shares $477,043.45 +6.3%0.9%3.8 $0.70 4/15/2023645,100 shares $490,276.00 -7.7%0.9%2.6 $0.76Has Trump Finally Gone Too Far? (Ad)Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover 3/31/2023698,800 shares $542,618.20 -2.8%0.9%1 $0.78 3/15/2023719,000 shares $540,328.50 +0.3%0.9%1 $0.75 2/28/2023716,600 shares $625,950.10 -13.8%0.9%1 $0.87 2/15/2023831,100 shares $706,435.00 -8.3%1.1%1.1 $0.85 1/31/2023905,900 shares $661,125.82 -49.1%1.2%1.2 $0.73 1/15/20231,780,000 shares $1.65 million +221.0%2.3%2.5 $0.93 12/30/2022554,600 shares $166,546.38 +0.3%0.7%1.7 $0.30 12/15/2022553,100 shares $182,523.00 +3.2%0.7%2.6 $0.33 11/30/2022535,800 shares $195,674.16 -2.5%0.7%2.9 $0.37 11/15/2022549,700 shares $241,813.03 -5.4%0.7%3.2 $0.44 10/31/2022581,200 shares $309,489.00 -9.9%0.8%3.9 $0.53 10/15/2022645,200 shares $296,727.48 -6.6%0.9%4.7 $0.46 9/30/2022691,000 shares $349,093.20 -6.3%0.9%4.9 $0.51 9/15/2022737,500 shares $441,025.00 -9.5%1.0%5.1 $0.60 8/31/2022814,700 shares $556,195.69 -15.3%1.1%5.2 $0.68 8/15/2022961,600 shares $712,834.08 -12.6%1.3%5.9 $0.74 7/31/20221,100,000 shares $594,000.00 +21.6%1.5%5.6 $0.54 7/15/2022904,700 shares $544,086.58 -7.7%1.2%4.6 $0.60 6/30/2022980,300 shares $561,221.75 -7.5%1.3%4.9 $0.57 6/15/20221,060,000 shares $717,620.00 -7.0%1.4%4.6 $0.68 5/31/20221,140,000 shares $889,314.00 -7.3%1.5%4.8 $0.78 5/15/20221,230,000 shares $852,390.00 -14.6%1.6%4.1 $0.69 4/30/20221,440,000 shares $1.33 million -9.4%1.9%4.6 $0.93 4/15/20221,590,000 shares $1.67 million -7.0%2.1%4.3 $1.05 3/31/20221,710,000 shares $2.21 million +8.2%2.3%4.2 $1.29 3/15/20221,580,000 shares $1.69 million -0.6%2.1%3 $1.07 2/28/20221,590,000 shares $1.75 million -5.4%2.1%2.8 $1.10 2/15/20221,680,000 shares $1.71 million -10.2%2.2%2.7 $1.02 1/31/20221,870,000 shares $1.83 million +2.2%2.5%2.6 $0.98 1/15/20221,830,000 shares $2.12 million -6.2%2.4%2.4 $1.16 12/31/20211,950,000 shares $2.22 million +2.6%2.6%2.6 $1.14 12/15/20211,900,000 shares $2.30 million +15.2%2.5%2.4 $1.21 11/30/20211,650,000 shares $2.05 million -7.8%2.2%1.5 $1.24 11/15/20211,790,000 shares $2.63 million -1.1%2.4%1.5 $1.47 10/29/20211,810,000 shares $2.59 million -11.3%2.4%1.5 $1.43 10/15/20212,040,000 shares $3.10 million +17.9%2.7%1.6 $1.52 9/30/20211,730,000 shares $2.65 million -40.1%2.3%1.1 $1.53 9/15/20212,890,000 shares $4.60 million +61.5%3.8%1.7 $1.59 8/31/20211,790,000 shares $2.88 million -10.5%2.4%0.9 $1.61 8/13/20212,000,000 shares $2.94 million -14.5%2.6%1.1 $1.47 7/30/20212,340,000 shares $3.60 million -2.1%3.1%1.2 $1.54 7/15/20212,390,000 shares $3.80 million +64.8%3.1%1.1 $1.59 6/30/20211,450,000 shares $2.87 million -13.7%1.9%0.7 $1.98 6/15/20211,680,000 shares $3.70 million +27.3%2.2%0.8 $2.20 5/28/20211,320,000 shares $2.24 million +6.5%1.7%0.4 $1.70 5/14/20211,240,000 shares $1.93 million -32.6%N/A0.3 $1.56 4/30/20211,840,000 shares $3.28 million -20.7%N/A0.3 $1.78 4/15/20212,320,000 shares $4.08 million -22.9%N/A0.4 $1.76 3/31/20213,010,000 shares $5.36 million +57.6%N/A0.5 $1.78 3/15/20211,910,000 shares $4.66 million -26.5%N/A0.3 $2.44Has Trump Finally Gone Too Far? (Ad)Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover 2/26/20212,600,000 shares $5.10 million +273.3%N/A0.5 $1.96 2/12/2021696,500 shares $1.98 million +159.7%N/A0.1 $2.84 1/29/2021268,200 shares $549,810.00 -6.8%N/A0.1 $2.05 1/15/2021287,600 shares $672,984.00 -58.0%N/A0.1 $2.34 12/31/2020685,100 shares $1.61 million +236.7%N/A0.4 $2.35 12/15/2020203,500 shares $386,650.00 -43.4%N/A0.1 $1.90 11/30/2020359,500 shares $607,555.00 +9.7%N/A0.4 $1.69 11/15/2020327,600 shares $956,592.00 +51.3%N/A1.5 $2.92 10/30/2020216,600 shares $723,444.00 -39.7%N/A0.9 $3.34 10/15/2020359,400 shares $1.25 million -26.7%N/A0.9 $3.47 9/30/2020490,500 shares $1.53 million +4.1%N/A0.9 $3.11 9/15/2020471,000 shares $1.53 million -22.7%N/A0.3 $3.25 HEPA Short Interest - Frequently Asked Questions What is Hepion Pharmaceuticals' current short interest? Short interest is the volume of Hepion Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of November 30th, traders have sold 47,200 shares of HEPA short. 0.68% of Hepion Pharmaceuticals' shares are currently sold short. Learn More on Hepion Pharmaceuticals' current short interest. What is a good short interest ratio for Hepion Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HEPA shares currently have a short interest ratio of 1.0. Learn More on Hepion Pharmaceuticals's short interest ratio. What is a good short interest percentage for Hepion Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.68% of Hepion Pharmaceuticals' floating shares are currently sold short. Is Hepion Pharmaceuticals' short interest increasing or decreasing? Hepion Pharmaceuticals saw a decrease in short interest in the month of November. As of November 30th, there was short interest totaling 47,200 shares, a decrease of 26.6% from the previous total of 64,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Hepion Pharmaceuticals' float size? Hepion Pharmaceuticals currently has issued a total of 6,958,000 shares. Some of Hepion Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Hepion Pharmaceuticals currently has a public float of 6,950,000 shares. How does Hepion Pharmaceuticals' short interest compare to its competitors? 0.68% of Hepion Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Hepion Pharmaceuticals: NRx Pharmaceuticals, Inc. (6.36%), Acurx Pharmaceuticals, Inc. (3.22%), Cara Therapeutics, Inc. (1.26%), Bright Green Co. (0.89%), TherapeuticsMD, Inc. (0.19%), HCW Biologics Inc. (0.65%), Marinus Pharmaceuticals, Inc. (7.94%), PharmaCyte Biotech, Inc. (0.75%), Sol-Gel Technologies Ltd. (0.70%), ANEW Medical, Inc. (1.67%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Hepion Pharmaceuticals stock? Short selling HEPA is an investing strategy that aims to generate trading profit from Hepion Pharmaceuticals as its price is falling. HEPA shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Hepion Pharmaceuticals? A short squeeze for Hepion Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HEPA, which in turn drives the price of the stock up even further. How often is Hepion Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HEPA, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies NRXP Short Interest Data ACXP Short Interest Data CARA Short Interest Data BGXX Short Interest Data TXMD Short Interest Data HCWB Short Interest Data MRNS Short Interest Data PMCB Short Interest Data SLGL Short Interest Data WENA Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:HEPA) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hepion Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hepion Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HEPA Stock Alerts